我国中药产品开发趋势：对2011—2015 年CFDA 批准中药的分析

UM > Institute of Chinese Medical Sciences

Status	已發表Published
	我国中药产品开发趋势：对2011—2015 年CFDA 批准中药的分析
Alternative Title	Development trend of Chinese materia medica products in China: An analysis of CFDA-approved Chinese materia medica (2011—2015)
	Song, Q; Hu, H.
	2017-06-01
Source Publication	中草药
ISSN	0253-2670
Pages	1262-1266
Abstract	To explore the innovation trend of Chinese materia medica (CMM) and provide reference for domestic research and development workers, we sorted out the drugs of CMM approved by China Food and Drug Administration (CFDA) during 2011—2015 through database retrieval, analyzed their drug categories, components, dosage forms, and therapeutic areas, and there were 176 approved CMM registration applications. Among all the 176 approved CMM registration applications, only two approved in class 3, and class 5 has 10, class 6 has 42, and others are three additional CMM categories of class 7—9. There are more compound preparations than on single preparations, and components focus on several key herbs such as Bupleurum and Salvia. Nine dosage forms are mostly focus on capsules and tablets. Therapeutic areas are focus on diseases of genitourinary system and circulatory system. It concludes that innovation of CMM needs to combine CMM theory, learn from modern research and development production technology, and focus on the urogenital system and other areas of increasing demand, and CFDA should also improve the efficiency of the review.
Keyword	Chinese materia medica China Food and Drug Administration registration application registration categories dosage form therapeutic area
Language	其他語言Others
The Source to Article	PB_Publication
PUB ID	32923
Document Type	Journal article
Collection	Institute of Chinese Medical Sciences
Corresponding Author	Hu, H.
Recommended Citation GB/T 7714	Song, Q,Hu, H.. 我国中药产品开发趋势：对2011—2015 年CFDA 批准中药的分析[J]. 中草药, 2017, 1262-1266.
APA	Song, Q., & Hu, H. (2017). 我国中药产品开发趋势：对2011—2015 年CFDA 批准中药的分析. 中草药, 1262-1266.
MLA	Song, Q,et al."我国中药产品开发趋势：对2011—2015 年CFDA 批准中药的分析".中草药 (2017):1262-1266.

Files in This Item:
There are no files associated with this item.

If you have any objections to this item, please fill out the form below and the administrator will contact you as soon as possible.
Content:
Email：	*
Affiliation No.
Verification Code:	Refresh

Any comments and suggestions are welcomed.
Title:	*
Content:
Email：	*
Verification Code:	Refresh